124 related articles for article (PubMed ID: 29205121)
21. An Integrative Informatics Approach to Explain the Mechanism of Action of N1-(Anthraquinon-2-yl) Amidrazones as BCR/ABL Inhibitors.
Sabbah DA; Hajjo R; Sweidan K; Zhong HA
Curr Comput Aided Drug Des; 2021; 17(6):817-830. PubMed ID: 32814537
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiproliferative activity of benzo[d]isothiazole hydrazones.
Vicini P; Incerti M; Doytchinova IA; La Colla P; Busonera B; Loddo R
Eur J Med Chem; 2006 May; 41(5):624-32. PubMed ID: 16540208
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors.
Sun J; Ren SZ; Lu XY; Li JJ; Shen FQ; Xu C; Zhu HL
Bioorg Med Chem; 2017 May; 25(9):2593-2600. PubMed ID: 28363444
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety.
Ma Y; Zheng X; Gao H; Wan C; Rao G; Mao Z
Molecules; 2016 Dec; 21(12):. PubMed ID: 27941680
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Biological Evaluation of Glycyrrhetic Acid Derivatives as Potential VEGFR2 Inhibitors.
Yan TL; Bai LF; Zhu HL; Zhang WM; Lv PC
ChemMedChem; 2017 Jul; 12(13):1087-1096. PubMed ID: 28599090
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of New Hydrazone Derivatives and Evaluation of their Efficacy as Proliferation Inhibitors in Human Cancer Cells.
Świątek P; Saczko J; Rembiałkowska N; Kulbacka J
Med Chem; 2019; 15(8):903-910. PubMed ID: 30686263
[TBL] [Abstract][Full Text] [Related]
27. In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study.
Kumar H; Raj U; Gupta S; Varadwaj PK
J Biomol Struct Dyn; 2016 Oct; 34(10):2171-83. PubMed ID: 26479578
[TBL] [Abstract][Full Text] [Related]
28. Novel benzothiazine-piperazine derivatives by peptide-coupling as potential anti-proliferative agents.
Venkatesh R; Kasaboina S; Bidayat D; Nikhil Kumar U; Jain N; Tangeda SJ; Bantu R; Janardhan S; Nagarapu L
Bioorg Med Chem Lett; 2017 Jan; 27(2):354-359. PubMed ID: 27964883
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity.
Chetan B; Bunha M; Jagrat M; Sinha BN; Saiko P; Graser G; Szekeres T; Raman G; Rajendran P; Moorthy D; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2010 Jul; 20(13):3906-10. PubMed ID: 20605448
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Anti-proliferative Activity of 4H-Chromone Based Phenylhydrazones, Pyrazolecarboxylates and Pyrazolylmethanones.
Rayala NR; Kommera R; Cherupally D; Murthy Thampunuri R; Shasi VK; Bhimapaka CR
Acta Chim Slov; 2018 Mar; 65(1):34-49. PubMed ID: 29562106
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
[TBL] [Abstract][Full Text] [Related]
32. Preparation of a series of novel bichalcones linked with a 1,4-dimethylenepiperazine moiety and examination of their cytotoxicity.
Reddy MV; Chen SS; Lin ML; Chan HH; Kuo PC; Wu TS
Chem Pharm Bull (Tokyo); 2011; 59(12):1549-54. PubMed ID: 22130379
[TBL] [Abstract][Full Text] [Related]
33. Acylhydrazone derivatives as potential anticancer agents: Synthesis, bio-evaluation and mechanism of action.
Yu X; Shi L; Ke S
Bioorg Med Chem Lett; 2015 Dec; 25(24):5772-6. PubMed ID: 26546214
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Khan E; Padhye S; Gaba H; Sinha S; Deshpande J; Venkateswara Swamy K; Khetmalas M; Ahmad A; Sarkar FH
Bioorg Med Chem Lett; 2012 May; 22(9):3104-8. PubMed ID: 22483392
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-tumor activities of N'-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives.
Lou J; Liu Z; Li Y; Zhou M; Zhang Z; Zheng S; Wang R; Li J
Bioorg Med Chem Lett; 2011 Nov; 21(22):6662-6. PubMed ID: 21986587
[TBL] [Abstract][Full Text] [Related]
37. New class of potent antitumor acylhydrazone derivatives containing furan.
Cui Z; Li Y; Ling Y; Huang J; Cui J; Wang R; Yang X
Eur J Med Chem; 2010 Dec; 45(12):5576-84. PubMed ID: 20884091
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; İşcan G; Kaplancıklı ZA
Eur J Med Chem; 2012 Dec; 58():299-307. PubMed ID: 23142671
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
Lee YB; Gong YD; Yoon H; Ahn CH; Jeon MK; Kong JY
Bioorg Med Chem; 2010 Nov; 18(22):7966-74. PubMed ID: 20943401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
